RGIN

REGENICIN INC by Regenicin, Inc. (RGIN)

About REGENICIN INC by Regenicin, Inc. (RGIN)

Regenicin, Inc. is a biotechnology company, which specializes in the development of regenerative cell therapies to restore the health of damaged tissues and organs. It intends to develop and commercialize a potentially lifesaving technology by the introduction of tissue-engineered skin substitutes to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds and a variety of plastic surgery procedures. The company was founded on September 6, 2007 and is headquartered in Las Vegas, NV.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
200
Dividend yield
0.00%
Volume
--
Avg. volume
9,737
P/E ratio
--

REGENICIN INC by Regenicin, Inc. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
200
Dividend yield
0.00%
Volume
--
Avg. volume
9,737
P/E ratio
--